<p>不幸的是，对于一些股东来说，<strong>MicroAlgo Inc.</strong>（纳斯达克代码：MLGO）的股价在过去三十天内下跌了 26%，延续了近期的痛苦。对于任何长期股东来说，上个月结束了一年值得遗忘的时光，锁定了 96% 的股价下跌。</p>
<p>由于股价大幅下跌，MicroAlgo 目前可能发出买入信号，其市销率（&#34;P/S&#34;）为 0.9 倍，考虑到美国 IT 行业几乎一半的公司市销率超过 2.2 倍，甚至市销率高于 9 倍的情况也并不罕见。然而，市销率低可能是有原因的，需要进一步调查以确定其合理性。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现的各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>查看我们对 MicroAlgo 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264"/></p>
<p>纳斯达克 CM:MLGO 市销率与行业比较 2025 年 12 月 30 日</p>
<h3>MicroAlgo 的市销率对股东意味着什么？</h3>
<p>例如，考虑到 MicroAlgo 最近的财务表现不佳，其收入一直在下降。一个可能性是，市销率低是因为投资者认为该公司在不久的将来无法避免表现不及整体行业。看好 MicroAlgo 的人希望情况不是这样，以便他们能够以较低的估值买入该股票。</p>
<p>想要了解公司收益、收入和现金流的完整情况吗？那么我们对 MicroAlgo 的 <strong>免费</strong> 报告将帮助您揭示其历史表现。</p>
<h2>MicroAlgo 是否有任何收入增长的预测？</h2>
<p>MicroAlgo 的市销率对于一家预计仅能实现有限增长的公司来说是典型的，重要的是，其表现还将低于行业水平。</p>
<p>回顾一下，公司的收入增长去年并没有让人兴奋，出现了令人失望的 28% 的下降。因此，三年前的收入总体也下降了 34%。所以不幸的是，我们必须承认该公司在这段时间内未能有效增长收入。</p>
<p>与行业相比，行业预计在未来 12 个月内将实现 19% 的增长，而该公司的近期中期收入结果所显示的下行趋势则是一个令人警醒的事实。</p>
<p>有了这些信息，我们并不感到惊讶 MicroAlgo 的市销率低于行业水平。尽管如此，考虑到收入在下降，市销率是否已经触底并没有保证。即使只是维持这些价格也可能很困难，因为近期的收入趋势已经对股价造成了压力。</p>
<h2>关键要点</h2>
<p>MicroAlgo 的市销率随着股价的下跌而下降。一般来说，我们倾向于将市销率的使用限制在确定市场对公司整体健康状况的看法上。</p>
<p>毫无疑问，MicroAlgo 在中期收入下滑的背景下维持其低市销率。在这个阶段，投资者认为收入改善的潜力不足以证明更高的市销率是合理的。考虑到当前的情况，如果近期中期收入趋势持续，股价在短期内出现显著波动的可能性似乎不大。</p>
<p>此外，您还应该了解我们发现的 <strong>MicroAlgo 的 3 个警告信号</strong>（其中 1 个不容忽视）。</p>
<p>如果您对 MicroAlgo 的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的基本面良好的公司呢？</p>
<p>用于国防和灾难的移动基础设施</p>
<p>下一波机器人技术不是类人型的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，随时随地。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

MLGO

<p>MicroAlgo Inc.（纳斯达克代码：MLGO）在过去一个月的股价下跌了 26%，年内累计下降了 96%。该公司的市销率（P/S）为 0.9 倍，远低于 IT 行业平均水平的 2.2 倍，显示出潜在的买入信号。然而，MicroAlgo 去年的收入下降了 28%，三年来下降了 34%，这引发了对其增长前景的担忧。投资者保持谨慎，因为低市销率反映了对未来收入改善的怀疑，暗示如果趋势持续，股价的波动空间有限</p>

<p>Unfortunately for some shareholders, the <strong>MicroAlgo Inc.</strong> (NASDAQ:MLGO) share price has dived 26% in the last thirty days, prolonging recent pain. For any long-term shareholders, the last month ends a year to forget by locking in a 96% share price decline.</p>
<div class="lb-trans"><p>不幸的是，对于一些股东来说，<strong>MicroAlgo Inc.</strong>（纳斯达克代码：MLGO）的股价在过去三十天内下跌了 26%，延续了近期的痛苦。对于任何长期股东来说，上个月结束了一年值得遗忘的时光，锁定了 96% 的股价下跌。</p>
</div><p>Since its price has dipped substantially, MicroAlgo may be sending buy signals at present with its price-to-sales (or &#34;P/S&#34;) ratio of 0.9x, considering almost half of all companies in the IT industry in the United States have P/S ratios greater than 2.2x and even P/S higher than 9x aren't out of the ordinary. However, the P/S might be low for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>由于股价大幅下跌，MicroAlgo 目前可能发出买入信号，其市销率（&#34;P/S&#34;）为 0.9 倍，考虑到美国 IT 行业几乎一半的公司市销率超过 2.2 倍，甚至市销率高于 9 倍的情况也并不罕见。然而，市销率低可能是有原因的，需要进一步调查以确定其合理性。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现的各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>View our latest analysis for MicroAlgo</p>
<div class="lb-trans"><p>查看我们对 MicroAlgo 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264" alt="" original-src="https://images.simplywall.st/asset/chart/693970316-ps-multiple-vs-industry-1-dark-2/1767090808264"/></p>
<p>NasdaqCM:MLGO Price to Sales Ratio vs Industry December 30th 2025</p>
<div class="lb-trans"><p>纳斯达克 CM:MLGO 市销率与行业比较 2025 年 12 月 30 日</p>
</div><h3>What Does MicroAlgo's P/S Mean For Shareholders?</h3>
<div class="lb-trans"><h3>MicroAlgo 的市销率对股东意味着什么？</h3>
</div><p>For example, consider that MicroAlgo's financial performance has been poor lately as its revenue has been in decline. One possibility is that the P/S is low because investors think the company won't do enough to avoid underperforming the broader industry in the near future. Those who are bullish on MicroAlgo will be hoping that this isn't the case so that they can pick up the stock at a lower valuation.</p>
<div class="lb-trans"><p>例如，考虑到 MicroAlgo 最近的财务表现不佳，其收入一直在下降。一个可能性是，市销率低是因为投资者认为该公司在不久的将来无法避免表现不及整体行业。看好 MicroAlgo 的人希望情况不是这样，以便他们能够以较低的估值买入该股票。</p>
</div><p>Want the full picture on earnings, revenue and cash flow for the company? Then our <strong>free</strong> report on MicroAlgo will help you shine a light on its historical performance.</p>
<div class="lb-trans"><p>想要了解公司收益、收入和现金流的完整情况吗？那么我们对 MicroAlgo 的 <strong>免费</strong> 报告将帮助您揭示其历史表现。</p>
</div><h2>Is There Any Revenue Growth Forecasted For MicroAlgo?</h2>
<div class="lb-trans"><h2>MicroAlgo 是否有任何收入增长的预测？</h2>
</div><p>MicroAlgo's P/S ratio would be typical for a company that's only expected to deliver limited growth, and importantly, perform worse than the industry.</p>
<div class="lb-trans"><p>MicroAlgo 的市销率对于一家预计仅能实现有限增长的公司来说是典型的，重要的是，其表现还将低于行业水平。</p>
</div><p>Taking a look back first, the company's revenue growth last year wasn't something to get excited about as it posted a disappointing decline of 28%. As a result, revenue from three years ago have also fallen 34% overall. So unfortunately, we have to acknowledge that the company has not done a great job of growing revenue over that time.</p>
<div class="lb-trans"><p>回顾一下，公司的收入增长去年并没有让人兴奋，出现了令人失望的 28% 的下降。因此，三年前的收入总体也下降了 34%。所以不幸的是，我们必须承认该公司在这段时间内未能有效增长收入。</p>
</div><p>Comparing that to the industry, which is predicted to deliver 19% growth in the next 12 months, the company's downward momentum based on recent medium-term revenue results is a sobering picture.</p>
<div class="lb-trans"><p>与行业相比，行业预计在未来 12 个月内将实现 19% 的增长，而该公司的近期中期收入结果所显示的下行趋势则是一个令人警醒的事实。</p>
</div><p>With this information, we are not surprised that MicroAlgo is trading at a P/S lower than the industry. Nonetheless, there's no guarantee the P/S has reached a floor yet with revenue going in reverse. Even just maintaining these prices could be difficult to achieve as recent revenue trends are already weighing down the shares.</p>
<div class="lb-trans"><p>有了这些信息，我们并不感到惊讶 MicroAlgo 的市销率低于行业水平。尽管如此，考虑到收入在下降，市销率是否已经触底并没有保证。即使只是维持这些价格也可能很困难，因为近期的收入趋势已经对股价造成了压力。</p>
</div><h2>The Key Takeaway</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><p>MicroAlgo's P/S has taken a dip along with its share price. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>MicroAlgo 的市销率随着股价的下跌而下降。一般来说，我们倾向于将市销率的使用限制在确定市场对公司整体健康状况的看法上。</p>
</div><p>It's no surprise that MicroAlgo maintains its low P/S off the back of its sliding revenue over the medium-term. At this stage investors feel the potential for an improvement in revenue isn't great enough to justify a higher P/S ratio. Given the current circumstances, it seems unlikely that the share price will experience any significant movement in either direction in the near future if recent medium-term revenue trends persist.</p>
<div class="lb-trans"><p>毫无疑问，MicroAlgo 在中期收入下滑的背景下维持其低市销率。在这个阶段，投资者认为收入改善的潜力不足以证明更高的市销率是合理的。考虑到当前的情况，如果近期中期收入趋势持续，股价在短期内出现显著波动的可能性似乎不大。</p>
</div><p>Plus, you should also learn about these <strong>3 warning signs we've spotted with MicroAlgo</strong> (including 1 which shouldn't be ignored).</p>
<div class="lb-trans"><p>此外，您还应该了解我们发现的 <strong>MicroAlgo 的 3 个警告信号</strong>（其中 1 个不容忽视）。</p>
</div><p>If you're <strong>unsure about the strength of MicroAlgo's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您对 MicroAlgo 的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的基本面良好的公司呢？</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>用于国防和灾难的移动基础设施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人型的。它是完全自主的塔，在 30 分钟内提供 5G、ISR 和雷达，随时随地。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

MicroAlgo Inc.（纳斯达克股票代码：MLGO）在股价下跌 26% 后显得便宜，但可能还不足以吸引投资者